. 2019 Jul 15;11(7):527–537. doi: 10.4251/wjgo.v11.i7.527

Table 2.

Summary of long-term survival outcomes in sarcopenic patients in eight studies

Ref.	No. of patients	Indication	Operation	Assessment of sarcopenia	Cut-off points for sarcopenia	Outcomes		P value
Peng et al[14], 2012	557	Pancreatic cancer	PD and DP	Total psoas index	Lowest quartile of the study cohort	3-yr survival, male	Sarcopenic: 20.3% Non-sarcopenic: 39.2%	< 0.05
Peng et al[14], 2012	557	Pancreatic cancer	PD and DP	Total psoas index	Lowest quartile of the study cohort	3-yr survival, female	Sarcopenic: 26.1% Non-sarcopenic: 40.8%	< 0.05
Amini et al[31], 2015	763	Pancreatic adenocarcinoma	PD, DP and TP	Total psoas volume (adjusted for height), total psoas index	Cut-off value from Peng et al[14]	OS	Sarcopenia as independent risk factor	< 0.001
Amini et al[31], 2015	763	Pancreatic adenocarcinoma	PD, DP and TP	Total psoas volume (adjusted for height), total psoas index	Cut-off value from Peng et al[14]	OS	UV: HR 1.72, 95%CI: 1.36–2.19 MV: HR 1.11, 95%CI: 1.11–1.91	0.006
Joglekar et al[46], 2015	180	Pancreatic adenocarcinoma	PD and DP	Total psoas index	Lowest quartile of the study cohort	OS	No significant difference	0.44
Okumura et al[45], 2015	230	Pancreatic adenocarcinoma	PD, DP and TP	Total psoas index (measured at umbilical level)	Calculated from receiver-operating characteristic curves	Median OS	Sarcopenic: 17.7 mo Non-sarcopenic: 33.2 mo	< 0.001
Okumura et al[45], 2015	230	Pancreatic adenocarcinoma	PD, DP and TP	Total psoas index (measured at umbilical level)	Calculated from receiver-operating characteristic curves	DFS	Significantly shorter survival in sarcopenic group	< 0.001
Onesti et al[66], 2016	270	Both benign and malignant conditions	PD, DP, central and TP	Total psoas area	Lowest tertile of the study cohort	OS	Significantly worse survival for sarcopenic group in females only	0.005
Ninomiya et al[67], 2017	265	Pancreatic adenocarcinoma	PD, DP and TP	Total abdominal muscle area (adjusted for height)	Cut-off value from Prado et al[39]	Median OS	Sarcopenic: 23.7 mo Non-sarcopenic: 25.8 mo	0.185
Van Dijk et al[47], 2017	199	Cancer of pancreatic head, ampulla, distal bile duct or duodenum	PD	Total abdominal muscle area (adjusted for height), radiation attenuation of skeletal muscle at L3	Lowest tertile of the study cohort	Median OS	No difference when total abdominal muscle area was compared	Not reported
Van Dijk et al[47], 2017	199		PD		Lowest tertile of the study cohort	Median OS	Significantly shorter survival in patients with low radiation attenuation	0.008
Sugimoto et al[68], 2018	323	Pancreatic adenocarcinoma	PD, DP and TP	Total abdominal muscle area (adjusted for height)	Cut-off value from Fearon et al[29]	OS	No significant difference	0.412
					Cut-off value from Fearon et al[29]	DFS	No significant difference	0.390
					Lowest quartile from study cohort	OS	No significant difference	0.075
					Lowest quartile from study cohort	DFS	No significant difference	0.172

PD: Pancreaticoduodenectomy; DP: Distal pancreatectomy; TP: Total pancreatectomy; OS: Overall survival; DFS: Disease-free survival; UV: Univariate analysis; HR: Hazard ratio; CI: Confidence interval; MV: Multivariate analysis.